🚦 Hazard Ratio (HR) - your survival trial’s speedometer! 🏁 Ever seen HR = 0.7 and wondered what it really means? Let’s decode 👇 🧭 HR compares how fast bad events happen ➡️ Death, relapse, or progression - whatever the trial tracks. 📊 Interpretation: ⚖️ HR = 1 → No

📌In our March issue Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial #OpenAccess here👉 https://t.co/ELzc8iF1vc #LiverTwitter

The best review on PSC that I have read https://t.co/2wDx2nObQF @HepCommJournal

EASL has released today a crucial position paper on the optimal management of patients cured of hepatitis C virus (HCV) following the advent of direct-acting antivirals (DAAs) covering: 🟢Follow-up for patients without advanced fibrosis, with compensated advanced chronic liver

Would you deny a therapy that increases 7-year survival from 13% to 64% ? If not, considering accepting EARLY liver TRANSPLANT for patients with Alcohol-related hepatitis. Great talk by Alexandre Louvet. #easlcongress #livertwitter @SALVE_liver @EASLedu

*NEW SERIES* edited by @serperm @yucaspice Functional status is critical in determining outcomes in cirrhosis. Nutrition: https://t.co/jx2n4uckpK Untangling sarcopenia, frailty, and fitness: https://t.co/4nn1Znjmby Series link (when all published) https://t.co/QSOdgFjjZu

It's been a long time coming! 1st paper from @METCon_Group out now in @LiverInt! Read it here: https://t.co/K1pE4mElfs Huge congrats team! So proud of all we accomplished and all we are looking forward to doing together! #Exercise #MASLD #LiverX @CJAPugh @djrcuthbertson

Congrats to Dr. Gideon Hirschfield and team for his spearheading a practice changing RCT on the role of Seladelpar in improving clinically relevant outcomes in patients with PBC with inadequate response to Ursodiol! Link below! https://t.co/FYXVFLhXuK

A UHN-led clinical trial has made a breakthrough in managing primary biliary cholangitis (PBC), a liver-related autoimmune disease with no known cure. Read more about the promising clinical trial led by #TeamUHN Physician Dr. Gideon Hirschfield ⬇ https://t.co/hWrSEY9Mkb

@AutoImmuneLiver excellent presentation highlighting positive study results. Great news for #PBC patients who need more treatment options that improve disease severity and quality of life. @AASLDtweets @PBCers

@ICESOntario @norahterrault @LizLeeNP @AASLDtweets

I'm so incredibly proud of my colleague who shined at The Liver Meeting, advocating passionately for patients with alcohol-related liver disease. ⁦@AASLDtweets⁩ ⁦@AASLDFoundation⁩ ⁦@LizLeeNP⁩ ⁦@AutoImmuneLiver⁩⁩ ⁦⁦@hepatoMD⁩ @zee_joanne⁩

@ICESOntario @norahterrault @LizLeeNP

Alcohol-related liver dx 🏥 encounters in people<38 yrs is rising at an alarming rate! @Jenn_Flemming shows 👉🏻median F/U 5yrs ➡️death in 25% 👉🏻🚺 experience worse outcomes (liver-related mortality, cirrhosis, decomp) 👉🏻 pay attention to sex and SES trends for at-risk people!

So proud of our @UHN liver nurse team for evaluating our safety data on an RN-led paracentesis model for pts with decompensated cirrhosis for our poster @ #TLM2023! Well utilized in 🇬🇧 but 1st in 🇨🇦 🇺🇸 🇲🇽 Congrats Molly- 🏆 Poster of Distinction & @AASLDFoundation awardee!

What an honor to be able to hear from Dr Kamath about how to develop a successful career with joy and humility. Also being able to sit next to you and listen to the story of the Meld score was such an unique experience! Thanks for the opportunity @AutoImmuneLiver @DrAliyaMD

How to doctor - a thread.

Long term follow-up in pediatric autoimmune liver disease- interesting study with fascinating results. 🔑biliary disease may not present until later in some patients!

Night time snack for #cirrhosis - Improves metabolism - Improves some outcomes - Increases muscle mass I enjoyed reading this review from @FedRavaioli And so will you Paper ( https://t.co/kOiWgonwC6) has: 1. ALL THE DATA 2. Tailored recommendations #livertwitter #meded

Grateful & excited to be a @CIHR_IRSC #VanierScholar for my ongoing graduate work in autoimmune liver disease epidemiology in Ontario inc. SES & exposome in devpt & prognosis! Many thanks to my mentors & pts who teach/humble/inspire me every day;can’t wait to pay it forward ➡️